Anna Rybachuk

9PUBLICATIONS
26CO-AUTHORS
AllergyGene and molecular therapySouth-East Asian languages (excl. Indonesian)Environmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 28, 2026
Subcutaneous Immunotherapy with Mannan-Conjugated Birch Pollen Allergoids in a Pre- and Co-Seasonal Treatment Regimen: An Exploratory Post Hoc Subgroup Analysis of Safety and Tolerability.

|Jun 12, 2026
Prospective Evaluation of Symptom Burden and Medication Use in Seasonal Allergic Rhinitis/Rhinoconjunctivitis Patients Considering Allergen-Specific Immunotherapy.

|Apr 30, 2026
Sustained Clinical Improvement in Birch Pollen Allergy After Two Pre-Seasonal Short Courses of Allergen-Specific Immunotherapy: A Long-Term Open-Label Extension Study.

|Dec 30, 2025
Correction: Gerstlauer et al. TAPAS-A Prospective, Multicentre, Long-Term Cohort Study in Children, Adolescents and Adults with Seasonal Allergic Rhinitis-Design and Early Results. J. Clin. Med. 2025, 14, 2609.

Michael Gerstlauer, Julia Hiller, Jennifer Raab

|Dec 11, 2025
Clinical Efficacy of One Short Course of Mannan-Conjugated Birch Pollen Allergoid Immunotherapy: A Comparative Evaluation After Prior Placebo Treatment.

Sandra Del Pozo, Natascha Wahrhusen, Oliver Pfaar

|Dec 11, 2025
Allergen Immunotherapy with Depigmented-Polymerised Cat Allergoid Is Safe and Well-Tolerated in Patients with Allergic Rhinitis/Rhinoconjunctivitis.

Ralph Mösges, Anna Rybachuk, Edmund Curtius

Pageof 2

Frequent Collaborators

6 joint publications

Cengizhan Acikel

5 joint publications

Ralph Mösges

5 joint publications

Christian Neuhof

4 joint publications

Miguel Casanovas